ESC 365 - EDEM2 is new therapeutic target for improving diabetes-induced cardiomyopathy by regulating DSG2

ESC2025 Premium Access

EDEM2 is new therapeutic target for improving diabetes-induced cardiomyopathy by regulating DSG2

Session: Pathophysiology and mechanisms in chronic heart failure (2)

Topic: Experimental Heart Failure

Speaker: Miss J. Zhang (Manchester, GB)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Miss Jiayan Zhang

University of Manchester, Manchester (United Kingdom of Great Britain & Northern Ireland)

0 follower

3 more presentations in this session

Global longitudinal strain evolution after cancer treatment in breast cancer females

Speaker: Doctor N. Amdouni Moussi (Tunis, TN)

Impact of the 2022 ESC/ERS guidelines on diagnosing pulmonary hypertension in heart failure with reduced ejection fraction patients undergoing elective right heart catheterization

Speaker: Mr F. Sawczak (Poznan, PL)

Sex differences in functional capacity and haemodynamic features in patients with dilated cardiomyopathy (DCM) with similar clinical characteristics

Speaker: Doctor F. Giardino (Naples, IT)

Access the full session

Pathophysiology and mechanisms in chronic heart failure (2)

Speakers: Miss J. Zhang, Doctor N. Amdouni Moussi, Mr F. Sawczak, Doctor F. Giardino

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources